litlas
Log inCreate account

Lisa Licitra

Active 1987–2025

205
Papers
34,802
Citations
88
h-index
188
i10-index

Citations

Citations per year for Lisa Licitra1988: 10 citations1989: 6 citations1990: 8 citations1991: 11 citations1992: 16 citations1993: 5 citations1994: 10 citations1995: 14 citations1996: 9 citations1997: 17 citations1998: 9 citations1999: 9 citations2000: 9 citations2001: 17 citations2002: 12 citations2003: 9 citations2004: 16 citations2005: 11 citations2006: 32 citations2007: 14 citations2008: 35 citations2009: 62 citations2010: 83 citations2011: 78 citations2012: 85 citations2013: 98 citations2014: 153 citations2015: 132 citations2016: 145 citations2017: 299 citations2018: 295 citations2019: 1,239 citations2020: 1,630 citations2021: 1,808 citations2022: 1,522 citations2023: 1,014 citations2024: 1,715 citations2025: 773 citations2026: 19 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,790 citing papers, 22.4% of this breakdownChina: 1,409 citing papers, 11.3% of this breakdownItaly: 885 citing papers, 7.1% of this breakdownGermany: 657 citing papers, 5.3% of this breakdownUnited Kingdom: 599 citing papers, 4.8% of this breakdownFrance: 561 citing papers, 4.5% of this breakdownJapan: 556 citing papers, 4.5% of this breakdownCanada: 384 citing papers, 3.1% of this breakdownSpain: 381 citing papers, 3.1% of this breakdownNetherlands: 361 citing papers, 2.9% of this breakdownAustralia: 311 citing papers, 2.5% of this breakdownBelgium: 261 citing papers, 2.1% of this breakdown
0%22.4%Other 26.4%

Institutions

Fields

  • Medicine77.5%
  • Biochemistry, Genetics and Molecular Biology14.4%
  • Immunology and Microbiology3.7%
  • Health Professions0.8%
  • Engineering0.7%
  • Dentistry0.5%
  • Other2.4%

Topics

  • Cancer Immunotherapy and Biomarkers10.2%
  • Head and Neck Cancer Studies9.8%
  • Immunotherapy and Immune Responses2.7%
  • Lung Cancer Treatments and Mutations2.4%
  • Thyroid Cancer Diagnosis and Treatment2.3%
  • Salivary Gland Tumors Diagnosis and Treatment2.3%
  • Other70.3%

Coauthors

All papers

Open in search
  1. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

    Authors: Barbara Burtness, Kevin J. Harrington, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett Hughes, Ricard Mesı́a, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Ruey‐Long Hong, René González Mendoza, Ananya Roy, Yayan Zhang, Burak Gümüşçü, Jonathan D. Cheng, Fan Jin, Danny Rischin, Guillermo Lerzo, Marcelo Tatangelo, Mirta Varela, Juan José Zarbá, Michael Boyer, Hui Gan, Bo Gao, Brett Hughes, Girish Mallesara, Danny Rischin, Anne L. Taylor, Martin Burian, Thorsten Fuereder, Richard Greil, Carlos H. Barrios, Dalvaro Oliveira de Castro Junior, Gilberto de Castro, Fábio Franke, Gustavo Girotto, Iane Pinto Figueiredo Lima, Ulisses Ribaldo Nicolau, Gustavo Dix Junqueira Pinto, Lucas Vieira dos Santos, Ana-Paula Victorino, Neil Chua, Félix Couture, Richard Gregg, Aaron R. Hansen, John Hilton, Joy McCarthy, Denis Soulières, Rodrigo Ascuí, Pablo Gonzalez, Luis J. Villanueva-Rivera, Marco Torregroza, Ángela R. Zambrano, Petra Holečková, Zdeněk Král, Bohuslav Melichar, Prausova Jana, Milan Vošmik, Maria Andersen, Niels Gyldenkerne, Hannes Jürgens, Kadri Putnik, Petri Reinikainen, Viktor Gruenwald, Simon Laban, Gerasimos Aravantinos, Ioannis Boukovinas, Vassilis Georgoulias, Amanda Psyrri, D.L.W. Kwong, Yousuf Al-Farhat, Tibor Csőszi, József Erfán, Geza Horvai, László Landherr, Éva Remenár, Ágnes Ruzsa, Judit Szota, Salem Billan, Iris Gluck, Orit Gutfeld, Aron Popovtzer, Marco Benasso, Simona Bui, Vittorio Ferrari, Lisa Licitra, Franco Nolè, Takashi Fujii, Yasushi Fujimoto, Nobuhiro Hanai, Hiroki Hara, Koji Matsumoto, Kenji Mitsugi and 119 more - The Lancet 2019 cited by 3,211

  2. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

    Authors: Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroline Even, Francis P. Worden, Nabil F. Saba, Lara Carmen Iglesias Docampo, Robert I. Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Manish Monga, Mark Lynch, William J. Geese, Justin Kopit, James W. Shaw, Maura L. Gillison - New England Journal of Medicine 2016 cited by 5,078

  3. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

    Authors: Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau, José Dinis, Lisa Licitra, Myung‐Ju Ahn, Ainara Soria, Jean‐Pascal Machiels, Nicolas Mach, Ranee Mehra, Barbara Burtness, Pingye Zhang, Jonathan D. Cheng, Ramona F. Swaby, Kevin J. Harrington, Mirelis Acosta-Rivera, Douglas R. Adkins, Morteza Aghmesheh, Myung‐Ju Ahn, Mario Airoldi, Eduardas Aleknavičius, Yousuf Al-Farhat, Alain P. Algazi, Salah Almokadem, Anna Alyasova, Jessica R. Bauman, Marco Benasso, Alfonso Berrocal, Victoria Bray, Barbara Burtness, Francesco Caponigro, Ana Castro, Terrence P. Cescon, Kelvin Chan, Arvind Chaudhry, Bruno Chauffert, Ezra E.W. Cohen, Tibor Csőszi, Jan Paul de Boer, Jean‐Pierre Delord, Andreas Dietz, José Dinis, Charlotte Dupuis, Laurence Digue, József Erfán, Yolanda Escobar Alvarez, Mererid Evans, Mary J. Fidler, Martin Förster, Signe Friesland, Apar Kishor Ganti, Lionnel Geoffrois, Clíona Grant, Viktor Gruenwald, Kevin J. Harrington, Thomas K. Hoffmann, Geza Horvai, Arturas Inčiūra, Raymond Woo-Jun Jang, Petra Jankowska, Antonio Jimeno, Mano Joseph, Alejandro Juárez Ramiro, Bogusława Karaszewska, Andrzej Kawecki, Ulrich Keilholz, Ulrich Keller, Sung‐Bae Kim, Judit Kocsis, Nuria Kotecki, Mark Kozloff, J. Lambea, László Landherr, Yuri Lantsukhay, Sergey Lazarev, Lip Way Lee, Christophe Le Tourneau, Lisa Licitra, Igor Lifirenko, Nicolas Mach, Danko Martincic, О. В. Маторин, Margaret McGrath, Jean‐Pascal Machiels, Ranee Mehra, Krzysztof Misiukiewicz, John C. Morris, Ф. Ф. Муфазалов, Jiaxin Niu, Devraj Srinivasan, Pedro Pérez Segura, Daniel Rauch, Maria Leonor Ribeiro, Cristina P. Rodriguez, Frédéric Rolland, Antonio Russo, Ágnes Ruzsa, Frederico Sanches, Sangwon Shin, Mikhail Shtiveland and 13 more - The Lancet 2018 cited by 1,697

  4. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: J.-P. Machiels, C. René Leemans, Wojciech Golusiński, Cai Grau, Lisa Licitra, Vincent Grégoire - Annals of Oncology 2020 cited by 865

  5. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

    Authors: Ezra E.W. Cohen, R. Bryan Bell, Carlo Bifulco, Barbara Burtness, Maura L. Gillison, Kevin J. Harrington, Quynh‐Thu Le, Nancy Y. Lee, Rom S. Leidner, Rebecca Lewis, Lisa Licitra, Hisham Mehanna, Loren K. Mell, Adam Raben, Andrew G. Sikora, Ravindra Uppaluri, Fernanda Whitworth, Dan P. Zandberg, Robert L. Ferris - Journal for ImmunoTherapy of Cancer 2019 cited by 738

  6. Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

    Authors: Robert L. Ferris, Robert I. Haddad, Caroline Even, Makoto Tahara, Mikhail Dvorkin, Tudor–Eliade Ciuleanu, Paul M. Clément, Ricard Mesı́a, С. И. Кутукова, Lyubov Zholudeva, Amaury Daste, Javier Caballero-Daroqui, Bhumsuk Keam, Ihor Vynnychenko, C. Lafond, Jagdish Shetty, Helen Mann, Jean Fan, Sophie Wildsmith, Nassim Morsli, Jérôme Fayette, Lisa Licitra - Annals of Oncology 2020 cited by 365

  7. Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression

    Authors: Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroline Even, Francis P. Worden, Nabil F. Saba, Lara Carmen Iglesias Docampo, Robert I. Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Mark Lynch, Vijayvel Jayaprakash, Li Li, Maura L. Gillison - Oral Oncology 2018 cited by 800

  8. Rare cancers are not so rare: The rare cancer burden in Europe

    Authors: Gemma Gatta, Jan Maarten van der Zwan, Paolo G. Casali, Sabine Siesling, Angelo Paolo Dei Tos, Ian Kunkler, R. Otter, Lisa Licitra, Sandra Mallone, Andrea Tavilla, Annalisa Trama, Riccardo Capocaccia - European Journal of Cancer 2011 cited by 785

  9. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

    Authors: Paolo Bossi, Anthony T.�C. Chan, Lisa Licitra, Annalisa Trama, Ester Orlandi, Edwin P. Hui, Jana Halámková, Stefan Mattheis, B. Baujat, José A. Hardillo, Ludi E. Smeele, C. van Herpen, Ana Castro, J-P. Machiels - Annals of Oncology 2020 cited by 424

  10. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

    Authors: Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra, Barbara Burtness, Makoto Tahara, Danny Rischin, Gustavo Vasconcelos Alves, Iane Pinto Figueiredo Lima, Brett Hughes, Y. Pointreau, Sercan Aksoy, Simon Laban, Richard Greil, Martin Burian, Marcin Hetnał, Jean‐Pierre Delord, Ricard Mesı́a, Miren Taberna, John Waldron, Christian Simon, Vincent Grégoire, Kevin J. Harrington, Ramona F. Swaby, Yayan Zhang, Burak Gümüşçü, Behzad Bidadi, Lillian L. Siu, Danny Rischin, Brett Hughes, Bo Gao, Margaret McGrath, Richard Greil, Dietmar Thurnher, Thorsten Fuereder, Martin Burian, Sylvie Rottey, Jean‐Pascal Machiels, Paul Clement, Stéphanie Henry, S. Deheneffe, Gustavo Vasconcelos Alves, Iane Pinto Figueiredo Lima, Josiane Mourão Dias, Pedro Rafael Martins De Marchi, Milena Perez Mak, Andrea Juliana Gomes, Dalvaro Oliveira de Castro Junior, Tatiane Cardoso Motta, Mônica Luciana Agostinho Padoan, Ana Paula Victorina, Sérgio Jobim Azevedo, Lillian L. Siu, Stephanie Yasmin Brule, John Hilton, Chang Shu Wang, Nathaniel Bouganim, Marc Webster, John Walker, Neil Chua, Ángela R. Zambrano, Alicia Quiroga Echeverri, Oscar Mauricio Niño Gomez, Carlos Alberto Ortiz, Luis Alejandro Rojas, Andrés Cardona Zorilla, Olga Marcela Urrego Meléndez, Petra Holečková, Bohuslav Melichar, Jakub Cvek, Jana Prausová, Milan Vošmik, Jean‐Pierre Delord, Xavier Zasadny, Lionnel Geoffrois, Yungan Tao, Y. Pointreau, Rainer Fietkau, Marlen Haderlein, Andreas Müller, Ursula C. Schroeder, Barbara Wollenberg, Simon Laban, Philipp Ivanyi, Viktor Gruenwald, Philippe Schafhausen, Orit Gutfeld, Iris Gluck, Aron Popovtzer, Amichay Meirovitz, Salem Billan, Baruch Brenner, Aron Popovtzer, Dror Limon, Lisa Licitra, Francesco Perri, Francesco Caponigro, Martina Violati, Daris Ferrari, Franco Nolè, Federica Bertolini and 90 more - The Lancet Oncology 2024 cited by 210

  11. Cabozantinib in Progressive Medullary Thyroid Cancer

    Authors: Rossella Elisei, Martin Schlumberger, Stefan Müller, Patrick Schöffski, Marcia S. Brose, Manisha H. Shah, Lisa Licitra, Barbara Jarząb, В. С. Медведев, Michael C. Kreißl, Bruno Niederle, Ezra E.W. Cohen, Lori J. Wirth, Haythem Ali, Colin Hessel, Yifah Yaron, Douglas W. Ball, Barry D. Nelkin, Steven I. Sherman - Journal of Clinical Oncology 2013 cited by 1,215

  12. Management of Salivary Gland Malignancy: ASCO Guideline

    Authors: J.L. Geiger, Nofisat Ismaila, Beth M. Beadle, Jimmy J. Caudell, Nicole G. Chau, Daniel G. Deschler, Christine M. Glastonbury, Marnie Kaufman, Eric Lamarre, Harold Lau, Lisa Licitra, Michael G. Moore, Cristina P. Rodriguez, Anna Roshal, Raja R. Seethala, Paul Swiecicki, Patrick K. Ha - Journal of Clinical Oncology 2021 cited by 405

  13. Tipifarnib in Head and Neck Squamous Cell Carcinoma WithHRASMutations

    Authors: Alan L. Ho, Irene Braña, Robert I. Haddad, Jessica R. Bauman, Keith C. Bible, Sjoukje F. Oosting, Deborah Jean Lee Wong, Myung‐Ju Ahn, Valentina Boni, Caroline Even, Jérôme Fayette, M.J. Flor, Kevin J. Harrington, David S. Hong, Sung‐Bae Kim, Lisa Licitra, Ioanna Nixon, Nabil F. Saba, Stephan Hackenberg, Pol Specenier, Francis P. Worden, Binaifer Balsara, Mollie Leoni, Bridget Martell, Catherine Scholz, Antonio Gualberto - Journal of Clinical Oncology 2021 cited by 196

  14. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

    Authors: Benjamin Lacas, Alexandra Carmel, C. Landais, Stuart J. Wong, Lisa Licitra, Jeffrey Tobias, Barbara Burtness, Maria Grazia Ghi, Ezra E.W. Cohen, Cai Grau, Gregory T. Wolf, Ricardo Hitt, Renzo Corvò, Volker Budach, Shaleen Kumar, Sarbani Ghosh Laskar, Jean‐Jacques Mazeron, Lai‐ping Zhong, W. Dobrowsky, Pirus Ghadjar, C. Fallai, Branko Zakotnik, Atul Sharma, René‐Jean Bensadoun, Maria Grazia Ruo Redda, S. Racadot, George Fountzilas, David M. Brizel, P Rovea, Athanassios Argiris, Zoltán Takácsi Nagy, Ju‐Whei Lee, Catherine Fortpied, Jonathan Harris, Jean Bourhis, Anne Aupérin, Pierre Blanchard, Jean‐Pierre Pignon, David J. Adelstein, M. Alfonsi, Y. Belkacemi, Voichita Bar‐Ad, J. Bernier, Åse Bratland, G. Calais, Brittany Campbell, Jimmy J. Caudell, Sylvie Chabaud, Emmanuel Chamorey, Devendra Chaukar, Kwang Nam Choi, Olivier Choussy, Laurence Collette, Judith Cruz, Carla Dani, Etienne Dauzier, Arlene A. Forastiere, P. Garaud, V. Grégoire, A. Hackshaw, E. Haddad, Bruce G. Haffty, Aaron R. Hansen, Stefanie Hayoz, Jean-Claude Horiot, Branislav Jeremić, Theodore Karrison, Johannes A. Langendijk, M. Lapeyre, Éric Lartigau, Traci Leong, Quynh‐Thu Le, Patricia Lee, Freddi Lewin, Aihua Lin, Alberto Lopes, Samir Mehta, James Moon, Elizabeth Moyal, Bob‐Valéry Occéan, P. Olmi, Roberto Orecchia, Brian O’Sullivan, Jens Overgaard, Claire Petit, Harvey Quon, Giuseppe Sanguineti, Tuvana Satar, John Simes, Christian Simon, Clément Sire, S. Staar, C. Stromberger, P. Strojan, Stéphane Temam, David Thomson, A. Timochenko, Valter Torri, Vassilikì Tseroni, Jan B. Vermorken and 5 more - Radiotherapy and Oncology 2021 cited by 376

  15. Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial

    Authors: Alexander Stratigos, Aleksandar Sekulić, Ketty Peris, Oliver Bechter, S. Prey, Martin Kaatz, Karl D. Lewis, Nicole Basset‐Séguin, Anne Lynn S. Chang, Stéphane Dalle, Almudena Fernández Orland, Lisa Licitra, Caroline Robert, Claas Ulrich, Axel Hauschild, Michael R. Migden, Reinhard Dummer, Siyu Li, Suk-Young Yoo, Kosalai Kal Mohan, Ebony Coates, Vladimir Janković, Nathalie Fiaschi, Emmanuel Chiebuka Okoye, Ioannis D. Bassukas, Carmen Loquai, Vincenzo De Giorgi, Zeynep Eroglu, Ralf Gutzmer, Jens Ulrich, Susana Puig, Frank Seebach, Gavin Thurston, David M. Weinreich, George D. Yancopoulos, Israel Lowy, Timothy G. Bowler, Matthew G. Fury - The Lancet Oncology 2021 cited by 278

  16. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study

    Authors: Gemma Gatta, Laura Botta, María‐José Sánchez, Lesley Anderson, Daniela Pierannunzio, Lisa Licitra, Monika Hackl, N. Zielonke, Willi Oberaigner, E. Van Eycken, K. Henau, Z. Valerianova, Nadya Dimitrova, Mario Šekerija, Miroslav Zvolský, Ladislav Dušek, Hans H. Storm, Gerda Engholm, Margit Mägi, Tiiu Aareleid, Nea Malila, Karri Seppä, Michel Velten, X. Troussard, Véronique Bouvier, Guy Launoy, A.V. Guizard, Jean Faivre, Anne‐Marie Bouvier, P. Arveux, Marc Maynadié, Anne‐Sophie Woronoff, Michel Robaszkiewicz, Isabelle Baldi, Alain Monnereau, Brigitte Trétarre, Nadine Bossard, Aurélien Belot, Marc Colonna, Florence Molinié, S. Bara, Claire Schvartz, B. Lapôtre‐Ledoux, Pascale Grosclaude, M. Meyer, Roland Stabenow, Sabine Luttmann, Andrea Eberle, Hermann Brenner, Alice Nennecke, Jutta Engel, G. Schubert-Fritschle, Joachim Kieschke, Jan Heidrich, Bernd Holleczek, Alexander Katalinic, Jón G. Jónasson, Laufey Tryggvadóttír, Harry Comber, Guido Mazzoleni, A. Bulatko, Carlotta Buzzoni, Adriano Giacomin, A. Mazzei A. Sutera Sardo, Stefano Ferretti, Emanuele Crocetti, Gianfranco Manneschi, Gemma Gatta, Milena Sant, H. Amash, C. Amati, Paolo Baili, Franco Berrino, S. Bonfarnuzzo, Laura Botta, F. Di Salvo, Roberto Foschi, C. Margutti, E. Meneghini, Pamela Minicozzi, Annalisa Trama, Diego Serraino, Antonella Zucchetto, Roberta De Angelis, M. Caldora, Riccardo Capocaccia, E. Carrani, Silvia Francisci, Sandra Mallone, Daniela Pierannunzio, P. Roazzi, Silvia Rossi, Mariano Santaquilani, Andrea Tavilla, Fabio Pannozzo, M. Natali, L Bonelli, Marina Vercelli, Valerio Gennaro, Paolo Ricci and 103 more - European Journal of Cancer 2015 cited by 485

  17. Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer

    Authors: Lori J. Wirth, Marcia S. Brose, Eric J. Sherman, Lisa Licitra, Martin Schlumberger, Steven I. Sherman, Keith C. Bible, Bruce Robinson, Patrice Rodien, Yann Godbert, Christelle de la Fouchardière, Kate Newbold, Christopher M. Nutting, Soamnauth Misir, Ran Xie, A. Almonte, Weifei Ye, Maria E. Cabanillas - Journal of Clinical Oncology 2021 cited by 121

  18. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

    Authors: Kevin J. Harrington, Robert L. Ferris, George R. Blumenschein, A. Dimitrios Colevas, Jérôme Fayette, Lisa Licitra, Stefan Kasper, Caroline Even, Everett E. Vokes, Francis P. Worden, Nabil F. Saba, Naomi Kiyota, Robert I. Haddad, Makoto Tahara, Viktor Grünwald, James W. Shaw, Manish Monga, Mark Lynch, Fiona Taylor, Michael DeRosa, L Morrissey, Kim Cocks, Maura L. Gillison, J. Guigay - The Lancet Oncology 2017 cited by 430

  19. Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma

    Authors: Martin Schlumberger, Rossella Elisei, Stefan Müller, Patrick Schöffski, Marcia S. Brose, Manisha H. Shah, Lisa Licitra, Jolanta Krajewska, Michael C. Kreißl, Bruno Niederle, Ezra E.W. Cohen, Lori J. Wirth, Haythem Ali, D O Clary, Yifah Yaron, Milan Mangeshkar, Douglas W. Ball, Barry D. Nelkin, Steven I. Sherman - Annals of Oncology 2017 cited by 239

  20. Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial

    Authors: Nicole Basset‐Séguin, Axel Hauschild, Rainer Kunstfeld, Jean‐Jacques Grob, Brigitte Dréno, Laurent Mortier, Paolo A. Ascierto, Lisa Licitra, Caroline Dutriaux, L. Thomas, Nicolás Meyer, B. Guillot, Reinhard Dummer, Petr Arenberger, Kate Fife, A. Raimundo, Emi Dika, Natalie Dimier, A. Fittipaldo, Ioannis Xynos, Johan Hansson - European Journal of Cancer 2017 cited by 284

  21. Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma

    Authors: Alice Baggi, Pietro Quaglino, Marco Rubatto, Roberta Depenni, Michele Guida, Paolo A. Ascierto, Claudia Trojaniello, Paola Queirolo, Maristella Saponara, Ketty Peris, Francesco Spagnolo, Luca Bianchi, Federica De Galitiis, Maria Concetta Potenza, Ilaria Proietti, Riccardo Marconcini, Andrea Botticelli, Vito Barbieri, Lisa Licitra, Salvatore Alfieri, Corrado Ficorella, Alessio Cortellini, Maria Concetta Fargnoli, Teresa Troiani, Luca Tondulli, Paolo Bossi - European Journal of Cancer 2021 cited by 107

  22. European Head and Neck Society recommendations for head and neck cancer survivorship care

    Authors: Irma M. Verdonck‐de Leeuw, Camilla Dawson, Lisa Licitra, Jesper Grau Eriksen, Şefik Hoşal, Susanne Singer, Dominic P Laverty, Wojciech Golusiński, Piotr Machczyński, Ana Varges Gomes, Charis Girvalaki, Christian Simon, C. René Leemans - Oral Oncology 2022 cited by 84

  23. 854O INTERLINK-1: Phase III study of cetuximab (CTX) ± monalizumab (M) in participants (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) with disease progression on/after platinum chemotherapy (CT) and previously treated with an immune checkpoint inhibitor (ICI)

    Authors: Jérôme Fayette, Lisa Licitra, Kevin J. Harrington, Robert I. Haddad, Lillian L. Siu, Yi‐Chun Liu, Makoto Tahara, J-P. Machiels, Danny Rischin, Tanguy Y. Seiwert, Robert L. Ferris, Ulrich Keilholz, Amanda Psyrri, Bhumsuk Keam, Paolo Bossi, Robert Metcalf, Oscar K. Serrano, Paramjit Kaur, Dario Ruscica, Roger B. Cohen - Annals of Oncology 2023 cited by 32

  24. Major and minor salivary gland tumors

    Authors: Marco Guzzo, Laura D. Locati, Franz J. Prott, Gemma Gatta, Mark McGurk, Lisa Licitra - Critical Reviews in Oncology/Hematology 2009 cited by 577